
Venture Capital vs. Revenue-Based Financing: Which Fits Your Business
Ray KowalskiOne trades equity for a shot at a huge outcome. The other trades a slice of revenue for control. The right answer depends on your growth math, not on hype.
Seed through late stage rounds reported with structure.

One trades equity for a shot at a huge outcome. The other trades a slice of revenue for control. The right answer depends on your growth math, not on hype.

Who writes the first checks, which instruments they use, and what has to be true for the money to turn into a company.

Public research money passes through agencies, universities and years of review before it ever reaches an experiment.

The two most common bridge instruments differ on interest, maturity and who carries the risk — and those differences decide who signs which one.

A down round reprices the company below its last raise, and for preferred holders with anti-dilution protection the adjustment formula can shift several percent of ownership from common shareholders back to investors in one signature.

Klarna's 2022 down round cut its valuation 85% to $6.7 billion from a $45.6 billion peak, according to the company's own announcement — and the anti-dilution and pay-to-play mechanics behind that reset apply to any startup that raises when growth hasn't caught up to its last price tag.